Aller au contenu
Black Friday — 30% OFFLivraison gratuite dès 99 € d’achat
  1. Accueil
  2. Santé hormonale et croissance
  3. GHRP-2 5mg
Santé hormonale

GHRP-2 5mg

GHRP-2 (Pralmorelin) is a synthetic hexapeptide compound studied for selective ghrelin receptor binding properties and growth hormone secretagogue signalling in experimental models.

Conditionnement: GHRP-2 5mg.

Sélectionnez le dosage et le conditionnement souhaités.

Conditionnement illustratif généré par IA.

Conditionnement
Le prix initial était : 199,50 €.Le prix actuel est : 139,65 €.

Disponible sur demande en France

Demander à un conseiller
Un conseiller vous contacte et la pharmacie partenaire vérifie si et comment la demande peut aboutir. Une ordonnance valide, ou une évaluation par un service de télémédecine autorisé, peut être nécessaire.
  • Pharmacie partenaire
  • Accompagnement personnalisé
  • Livraison discrète
  • Conditionnement
    GHRP-2 5mg

Expédition et livraison

  • Expédition habituellement sous 24 heures après confirmation du paiement.
  • USPS Regular Shipping · 11,95 € · Env. 3–5 jours ouvrés
  • FedEx 2 Days Delivery · 28,99 € · Env. 2 jours ouvrés
  • FedEx Overnight Delivery · 40,99 € · Env. 1 jour ouvré

Réservé à la recherche en laboratoire.

Ne pas utiliser chez l’être humain ou l’animal.

Composition et détails du produit

Présentation

GHRP-2 (Pralmorelin) is a synthetic hexapeptide compound studied for selective ghrelin receptor binding properties and growth hormone secretagogue signalling in experimental models.

The compound consists of six amino acids (D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH2) and is examined for its capacity to engage the GHS-R1a (growth hormone secretagogue receptor 1a) in pituitary and hypothalamic research models. Research applications include ghrelin receptor pharmacology, growth hormone secretagogue pathway studies, and pulsatile GH signalling research.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Propriétés

Chemical Formula C45H55N9O6
Synonyms Pralmorelin, KP-102, D-Alanyl-3-(2-naphthalenyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide, UNII-E6S6E1F19M
Molar Mass 817.9865 g/mol
CAS Number 158861-67-7
PubChem CID 6918245
Formats disponibles GHRP-2 5mg (1 vial) · GHRP-2 5mg KIT (10 vials)
Shelf Life 36 months

Recherche

GHRP-2 (Pralmorelin) is a synthetic hexapeptide studied as a potent agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a) in laboratory research models. The compound’s six-amino-acid sequence (D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH2) is studied for selective receptor binding at GHS-R1a sites located in pituitary somatotroph cells and hypothalamic nuclei, with downstream research interest in pulsatile growth hormone secretagogue signalling and IGF-1 axis modulation. Research models have also examined GHRP-2’s proposed somatostatin suppression activity — studied as a mechanism through which it may amplify growth hormone release beyond direct receptor agonism — and its capacity to modulate cAMP production, calcium mobilization, and PKA/PKC signalling cascades in pituitary cell models. Independently third-party HPLC-tested; COA available per batch.

FAQ

What receptor does GHRP-2 bind to and how is this studied in laboratory models?

GHRP-2 is studied for selective agonist activity at the GHS-R1a (growth hormone secretagogue receptor 1a), which is expressed in pituitary somatotroph cells and hypothalamic nuclei. Cell-based binding assays using GHS-R1a-expressing cell lines, alongside downstream signalling readouts (such as cAMP accumulation and calcium mobilization), are standard methods for characterising GHRP-2’s receptor engagement and functional potency relative to other GHS-R1a ligands.

What distinguishes GHRP-2’s proposed mechanism from GHRH-based research tools?

GHRP-2 engages the ghrelin/GHS-R1a receptor pathway, distinct from the GHRH receptor pathway targeted by GHRH analogues such as CJC-1295. Research protocols frequently pair GHRP-2 with GHRH analogues to examine whether GHS-R1a agonism and GHRH receptor activation produce synergistic effects on growth hormone secretagogue signalling endpoints, a common combination design in pituitary pathway research.

What experimental controls are commonly used in GHRP-2 receptor-signalling research?

Studies investigating GHRP-2 mechanisms typically incorporate vehicle controls, receptor-antagonist controls, and comparator GHS-R1a agonists to distinguish receptor-specific effects from non-specific pathway activation.

Comparative experiments using compounds such as GHRP-6 or Ipamorelin are commonly employed to evaluate differences in signalling selectivity, pathway activation patterns, receptor responsiveness, and downstream transcriptional responses. These approaches help establish mechanistic attribution in GHS-R1a pharmacology research.

Le prix initial était : 199,50 €.Le prix actuel est : 139,65 €.